Pharmaceutical form

Eye drops 2.5 mL.


1 mL contains 0.05 mg of latanoprost, 5 mg of timolol.

Product characteristics

It is prescribed with insufficient response to the treatment of glaucoma with β-blockers or prostaglandin analogs. It lowers intraocular pressure through a combination of various mechanisms of action: decreased secretion and increased aqueous humour outflow. Hypotensive action begins after an hour and lasts for 24 hours.

Posology and method of administration

Instil 1 drop to the affected eye(s) once daily.

Therapeutic indications

To lower intraocular pressure in patients with open-angle glaucoma and elevated intraocular pressure with insufficient response to treatment with topical beta-blockers or prostaglandin analogs.

Download instruction: LaproNext-combi.pdf